Latest Transmyocardial revascularization Stories
ATLANTA, Nov. 24, 2014 /PRNewswire/ -- CryoLife, Inc.
ATLANTA, Aug. 5, 2014 /PRNewswire/ --CryoLife, Inc.
ATLANTA, and IRVINE, Calif., May 17, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation ("Cardiogenesis").
IRVINE, Calif., April 20, 2011 /PRNewswire/ -- Cardiogenesis Corporation (OTCQB: CGCP) announced that the company will release results for its first quarter ended March 31, 2011 on Wednesday, May 4, 2011. The company added that Paul J. McCormick, its Executive Chairman, and William R.
IRVINE, Calif., Feb, 23, 2011 /PRNewswire/ -- Cardiogenesis Corporation (Pink Sheets: CGCP) announced that the company will release results for its fourth quarter and full-year ended December 31, 2010 on Wednesday, March 9, 2011. The company added that Paul J.
FRANKLIN, Mass., Feb. 2, 2011 /PRNewswire/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative medical device-based technologies, today announced that it had completed the sale of its Transmyocardial Revascularization (TMR) business to Novadaq Technologies Inc.
Treatment that included early surgical procedures to open blocked arteries resulted in better blood flow to the heart than aggressive medical treatment alone in patients with both diabetes and heart disease.
FRANKLIN, Mass., Nov. 8, 2010 /PRNewswire-FirstCall/ -- PLC Systems Inc.
IRVINE, Calif., Nov.
- In medieval musical notation, a sign or neume denoting a shake or trill.